“…While there is a consensus that P-gp levels in human placenta decline with gestational age, controversial results exist regarding the changes of BCRP expression in human placenta over gestation [40,71]. P-gp and BCRP expression in the placenta could be regulated at the transcriptional, translational and post-translational levels [79,83,89,136]. Recent studies indicate that the roles of P-gp (likely BCRP as well) in determining fetal drug exposure depend on drugs administered even if the drugs are their substrates, a phenomenon that could be interpreted by the concept of fraction of drug transported [51,56,57,61,80,91,92,95,137,138].…”